Related Experiment Videos
An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized
Sherryl A Jeffries1, John W Robinson, Peter S Craighead
1Department of Psychosocial Resources, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
Summary
A psychoeducational intervention effectively improved adherence to vaginal dilation recommendations for gynecologic cancer patients undergoing pelvic radiotherapy. This study highlights a successful strategy to enhance treatment compliance and manage side effects.
Area of Science:
- Oncology
- Behavioral Science
- Gynecology
Background:
- Vaginal dilation is recommended to prevent scarring after pelvic radiotherapy for gynecologic cancer.
- Historically, patient compliance with vaginal dilation has been very low, necessitating improved intervention strategies.
Purpose of the Study:
- To evaluate the effectiveness of a psychoeducational intervention designed to increase compliance with vaginal dilation.
- To address the low adherence rates observed in patients undergoing pelvic radiotherapy for gynecologic malignancies.
Main Methods:
- A randomized controlled trial was conducted with 42 women diagnosed with cervical or endometrial cancer.
- Participants received pelvic radiotherapy and were randomized to a psychoeducational intervention group or an information-only control group.
- Assessments included questionnaires and interviews at multiple follow-up points up to 24 months.
Main Results:
- The psychoeducational intervention group demonstrated significantly increased compliance with vaginal dilation compared to the control group.
- The intervention proved successful in enhancing adherence to recommended vaginal dilation practices.
Conclusions:
- This is the first randomized controlled study to show that a psychoeducational intervention can effectively improve compliance with vaginal dilator use.
- The findings support the use of targeted psychoeducational strategies to improve treatment adherence and outcomes in gynecologic cancer survivors.